BR112012009423A2 - método de alívio de crescimento de cãncer ou de um simtoma de cãncer, método de sensibilização de ccâncer a fármacos quimioterápicos, método de sensibilização de câncer à radioterapia e pacote de refeição terapêutica para fornecer refeições para um paciente com cãncer que retarda crescimento de cãncer e intensifica a eficácia de fármacos quimioterápicos - Google Patents
método de alívio de crescimento de cãncer ou de um simtoma de cãncer, método de sensibilização de ccâncer a fármacos quimioterápicos, método de sensibilização de câncer à radioterapia e pacote de refeição terapêutica para fornecer refeições para um paciente com cãncer que retarda crescimento de cãncer e intensifica a eficácia de fármacos quimioterápicosInfo
- Publication number
- BR112012009423A2 BR112012009423A2 BR112012009423A BR112012009423A BR112012009423A2 BR 112012009423 A2 BR112012009423 A2 BR 112012009423A2 BR 112012009423 A BR112012009423 A BR 112012009423A BR 112012009423 A BR112012009423 A BR 112012009423A BR 112012009423 A2 BR112012009423 A2 BR 112012009423A2
- Authority
- BR
- Brazil
- Prior art keywords
- cancer
- growth
- sensitization method
- chemotherapy
- intensifies
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/60—Comminuted or emulsified meat products, e.g. sausages; Reformed meat from comminuted meat product
- A23L13/65—Sausages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/20—Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Business, Economics & Management (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tourism & Hospitality (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Economics (AREA)
- Entrepreneurship & Innovation (AREA)
- Human Resources & Organizations (AREA)
- Marketing (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Strategic Management (AREA)
- General Business, Economics & Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25415409P | 2009-10-22 | 2009-10-22 | |
| PCT/US2010/053821 WO2011050302A2 (en) | 2009-10-22 | 2010-10-22 | Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012009423A2 true BR112012009423A2 (pt) | 2017-06-13 |
Family
ID=43900993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012009423A BR112012009423A2 (pt) | 2009-10-22 | 2010-10-22 | método de alívio de crescimento de cãncer ou de um simtoma de cãncer, método de sensibilização de ccâncer a fármacos quimioterápicos, método de sensibilização de câncer à radioterapia e pacote de refeição terapêutica para fornecer refeições para um paciente com cãncer que retarda crescimento de cãncer e intensifica a eficácia de fármacos quimioterápicos |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20110118528A1 (enExample) |
| EP (1) | EP2490684B1 (enExample) |
| JP (1) | JP2013508411A (enExample) |
| CN (1) | CN102753162A (enExample) |
| AU (2) | AU2010310515B2 (enExample) |
| BR (1) | BR112012009423A2 (enExample) |
| CA (1) | CA2779282C (enExample) |
| DK (1) | DK2490684T3 (enExample) |
| ES (1) | ES2659353T3 (enExample) |
| PL (1) | PL2490684T3 (enExample) |
| PT (1) | PT2490684T (enExample) |
| RU (1) | RU2549954C2 (enExample) |
| WO (1) | WO2011050302A2 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014066426A1 (en) | 2012-10-22 | 2014-05-01 | University Of Southern California | Methods and formulations promoting tissue/organ regeneration, longevity and healthspan |
| EP3510875B1 (en) * | 2013-02-12 | 2020-06-10 | University of Southern California | Diet composition for use in a therapeutic method of lowering blood glucose and/or igf-1 levels |
| CN105431055A (zh) | 2013-07-01 | 2016-03-23 | 南加利福尼亚大学 | 作为糖尿病食疗的禁食条件 |
| MX383483B (es) * | 2014-03-06 | 2025-03-14 | Univ Southern California | Utilización de régimen de ayuno a corto plazo en combinación con inhibidores de cinasa para potenciar la eficacia y viabilidad de fármacos quimioterápicos tradicionales e invertir los efectos secundarios de cinasas en células y tejidos normales. |
| US10172839B2 (en) | 2014-03-06 | 2019-01-08 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
| EP3122354B1 (en) | 2014-03-28 | 2022-06-15 | Universita' degli Studi di Genova | Tyrosine kinase inhibitors for use in a method of treating cancer in association with a reduced caloric intake |
| WO2015153850A2 (en) * | 2014-04-02 | 2015-10-08 | University Of Southern California | Autoimmunity and multiple sclerosis treatment |
| HK1249858A1 (zh) | 2015-04-16 | 2018-11-16 | 南加利福尼亚大学 | 响应於雷帕霉素和地塞米松诱导的标准和高葡萄糖条件禁食模仿膳食(fmd)和降葡萄糖药物保护正常细胞并产生癌症敏感条件 |
| US11000057B2 (en) | 2015-05-06 | 2021-05-11 | University Of Southern California | Fasting mimicking and enhancing diet for treating hypertension and lipid disorders |
| CN108601838A (zh) * | 2015-09-21 | 2018-09-28 | 意大利癌症研究基金会分子肿瘤学研究所(Ifom) | 对抗血液癌症的新治疗策略 |
| HK1258621A1 (zh) * | 2016-01-12 | 2019-11-15 | 南加利福尼亚大学 | 长期禁食模仿作为多发性骨髓瘤和其他癌症的膳食治疗的用途 |
| BR112018016494A2 (pt) | 2016-02-15 | 2018-12-26 | University Of Southern California | método para promover regeneração de célula pancreática e reprogramação de célula somática; e pacote de dieta |
| EP3419615A1 (en) | 2016-02-23 | 2019-01-02 | Cancer Research Technology Ltd. | Dietary product devoid of at least two non essential amino acids |
| CN109152790A (zh) | 2016-05-11 | 2019-01-04 | 南加利福尼亚大学 | 禁食模仿膳食作为胃肠自身免疫性/炎性疾病的免疫调节治疗剂 |
| IT201700008499A1 (it) | 2017-01-26 | 2018-07-26 | Univ Degli Studi Genova | Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio |
| US11284640B2 (en) | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
| CN107951892A (zh) * | 2018-01-19 | 2018-04-24 | 丽水学院 | 锌原卟啉在制备增强人结直肠癌细胞对5-氟尿嘧啶化疗敏感性药物中的应用 |
| BR112020018564A2 (pt) | 2018-03-15 | 2020-12-29 | University Of Southern California | Composição probiótica para doença gastrointestinal autoimune e/ou inflamatória, uso de uma dieta que simula jejum para prevenir ou tratar doença gastrointestinal autoimune e/ou inflamatória, e suplemento dietário |
| US20210267250A1 (en) * | 2018-07-18 | 2021-09-02 | Andreas Michalsen | Effects of a short-term fasting mimicking diet on quality of life and tolerance to chemotherapy in patients with cancer |
| JP2022515707A (ja) | 2018-11-09 | 2022-02-22 | エル－ニュートラ | 断続的断食模倣のための栄養バー |
| WO2020223522A1 (en) | 2019-04-30 | 2020-11-05 | University Of Southern California | Fasting-mimicking diet (fmd) as an intervention for alzheimer's disease (ad) |
| JP6747702B1 (ja) * | 2019-05-10 | 2020-08-26 | 株式会社医療情報技術研究所 | 栄養処方管理システム |
| AU2020276605A1 (en) | 2019-05-14 | 2022-01-20 | Tyme, Inc. | Compositions and methods for treating cancer |
| IT201900009954A1 (it) * | 2019-06-24 | 2020-12-24 | Fondazione Irccs Istituto Naz Dei Tumori | Preparazione alimentare a basso contenuto calorico per l’alimentazione di pazienti affetti da neoplasie |
| JP7376718B2 (ja) * | 2019-12-13 | 2023-11-08 | 株式会社ベリタスバイオセラピューティクス | 癌の予防または治療用薬学組成物 |
| IT202000007153A1 (it) | 2020-04-03 | 2021-10-03 | Ifom Fondazione St Firc Di Oncologia Molecolare | Apporto calorico ridotto e immunoterapia per il trattamento del cancro |
| US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
| WO2021247724A1 (en) | 2020-06-03 | 2021-12-09 | Faeth Therapeutics, Inc. | Formulations for personalized methods of treatment |
| US12109184B2 (en) | 2020-06-04 | 2024-10-08 | Faeth Therapeutics, Inc. | Personalized methods of treating cancer |
| TW202227113A (zh) | 2020-12-01 | 2022-07-16 | 南加州州立大學 | 模擬禁食飲食提升急性淋巴母細胞白血病模型中的無癌存活 |
| WO2022130420A1 (en) * | 2020-12-17 | 2022-06-23 | Fondazione Irccs Istituto Nazionale Dei Tumori | Diet preparation for the nutrition of cancer patients with a restricted calorie intake |
| EP4066823B1 (en) | 2021-03-30 | 2025-04-30 | IFOM - Istituto Fondazione di Oncologia Molecolare ETS | Reduced caloric intake and anticancer agents for the treatment of cancer |
| CN115590963A (zh) * | 2022-07-13 | 2023-01-13 | 复旦大学（Cn） | 酮体、酮体诱导剂和生酮组合物中的至少一种在治疗和/或预防血小板减少症药物中的应用 |
| EP4599826A1 (en) | 2024-02-06 | 2025-08-13 | IFOM - Istituto Fondazione di Oncologia Molecolare ETS | Leucine for use in the treatment of cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2074731C1 (ru) * | 1994-12-29 | 1997-03-10 | Игорь Александрович Бойко | Фитокомплекс, обладающий противоопухолевым действием, и способ лечения онкологических больных |
| AU749638B2 (en) * | 1997-03-17 | 2002-06-27 | Btg International Limited | Therapeutic compositions |
| WO2001006983A2 (en) * | 1999-07-22 | 2001-02-01 | Incell Corporation, Llc | Fatty acids to minimize cancer therapy side effects |
| JP4625156B2 (ja) * | 2000-04-10 | 2011-02-02 | イーエヌ大塚製薬株式会社 | 癌化学療法に伴う副作用軽減剤 |
| US20070275934A1 (en) * | 2004-05-10 | 2007-11-29 | Curd John G | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments |
| AU2005296271A1 (en) * | 2004-10-15 | 2006-04-27 | University Of Tennessee Research Foundation | Methods for inducing apoptosis in adipocytes |
| US20070116802A1 (en) * | 2005-11-23 | 2007-05-24 | Carl Germano | High quality caloric composition |
| US20080038367A1 (en) * | 2006-08-11 | 2008-02-14 | Sal Saloum | Nutritional supplement compositions and methods of preparing |
| RU2354369C2 (ru) * | 2007-03-16 | 2009-05-10 | Михаил Владимирович Кутушов | Применение родамина 6ж в качестве лекарственного средства для лечения злокачественных новообразований и амилоидозов |
| WO2008119077A1 (en) * | 2007-03-28 | 2008-10-02 | University Of Southern California | Induction of differential stress resistance and uses thereof |
| CN101868235A (zh) * | 2007-11-26 | 2010-10-20 | 雀巢产品技术援助有限公司 | 抑制dsRNA-依赖性蛋白激酶激活和抑制肿瘤生长的组合物和方法 |
-
2010
- 2010-10-22 ES ES10825771.8T patent/ES2659353T3/es active Active
- 2010-10-22 RU RU2012118588/15A patent/RU2549954C2/ru active
- 2010-10-22 EP EP10825771.8A patent/EP2490684B1/en active Active
- 2010-10-22 PT PT108257718T patent/PT2490684T/pt unknown
- 2010-10-22 CA CA2779282A patent/CA2779282C/en active Active
- 2010-10-22 DK DK10825771.8T patent/DK2490684T3/en active
- 2010-10-22 BR BR112012009423A patent/BR112012009423A2/pt not_active Application Discontinuation
- 2010-10-22 JP JP2012535426A patent/JP2013508411A/ja active Pending
- 2010-10-22 AU AU2010310515A patent/AU2010310515B2/en active Active
- 2010-10-22 US US12/910,508 patent/US20110118528A1/en not_active Abandoned
- 2010-10-22 CN CN2010800560747A patent/CN102753162A/zh active Pending
- 2010-10-22 PL PL10825771T patent/PL2490684T3/pl unknown
- 2010-10-22 WO PCT/US2010/053821 patent/WO2011050302A2/en not_active Ceased
-
2016
- 2016-03-11 AU AU2016201607A patent/AU2016201607B2/en active Active
-
2021
- 2021-03-17 US US17/204,419 patent/US20210209516A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2490684A2 (en) | 2012-08-29 |
| PT2490684T (pt) | 2018-04-02 |
| AU2016201607A1 (en) | 2016-03-31 |
| DK2490684T3 (en) | 2018-04-09 |
| CA2779282A1 (en) | 2011-04-28 |
| EP2490684B1 (en) | 2018-01-03 |
| US20210209516A1 (en) | 2021-07-08 |
| WO2011050302A2 (en) | 2011-04-28 |
| RU2012118588A (ru) | 2013-11-27 |
| RU2549954C2 (ru) | 2015-05-10 |
| PL2490684T3 (pl) | 2018-07-31 |
| CA2779282C (en) | 2017-12-05 |
| ES2659353T3 (es) | 2018-03-14 |
| EP2490684A4 (en) | 2016-05-04 |
| CN102753162A (zh) | 2012-10-24 |
| AU2010310515B2 (en) | 2016-01-07 |
| AU2010310515A1 (en) | 2012-05-17 |
| WO2011050302A3 (en) | 2011-08-25 |
| JP2013508411A (ja) | 2013-03-07 |
| AU2016201607B2 (en) | 2017-11-30 |
| US20110118528A1 (en) | 2011-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012009423A2 (pt) | método de alívio de crescimento de cãncer ou de um simtoma de cãncer, método de sensibilização de ccâncer a fármacos quimioterápicos, método de sensibilização de câncer à radioterapia e pacote de refeição terapêutica para fornecer refeições para um paciente com cãncer que retarda crescimento de cãncer e intensifica a eficácia de fármacos quimioterápicos | |
| BR112013011480A2 (pt) | método de tratamento de câncer, método de aumento da eficácia terapêutica de uma droga anticâncer, pmo1183 ou um sal farmaceuticamente aceitável do mesmo, uso do mesmo e kit para uso no tratamento de câncer | |
| BR112012000862A8 (pt) | composição farmacêutica oral, composição farmacêutica oral de baixa dose para administração crônica, método de tratamento ou retardo do inicio ou desenvolvimento de uma condição, método de tratamento da dor em um indivíduo que necessita deste medicamento, método de tratamento de uma condição em um indivíduo que necessita deste medicamento | |
| AR124500A2 (es) | Aumento de la biodisponibilidad de droga en terapia naltrexona | |
| BR112012018022A2 (pt) | inibição de sinalização axl em terapia antimetastática. | |
| BR112012017150A2 (pt) | formulação de anticorpo e regimes terapêuticos. | |
| PL3599237T3 (pl) | Kompozycja farmaceutyczna inhibitora syntazy glukozyloceramidowej eliglustatu do leczenia choroby Gauchera obejmującego dostosowanie indywidualnej dawki terapeutycznej do metabolizmu P450 pacjenta | |
| MX2014010913A (es) | Composicion farmaceutica que comprende farmaco empagliflozina y antiobesidad. | |
| SG11202111929TA (en) | Methods and systems for providing personalised medicine to a patient | |
| BRPI0813513A2 (pt) | Terapia específica e medicamento usando ligantes de integrina para tratamento de câncer | |
| GT201400059A (es) | Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos | |
| BR112012005044A2 (pt) | composições que compreendem tramadol e celecoxib no tratamento de dor. | |
| BRPI0821248A2 (pt) | Inibidores de cinesina como fármacos terapêuticos para câncer | |
| ES2425315R1 (es) | Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento sintomático de una enfermedad o afección respiratoria | |
| BR112015006656A8 (pt) | composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos | |
| NZ700924A (en) | Dosage regimen for a pi-3 kinase inhibitor | |
| BR112014018450A8 (pt) | Fenilimidazopirazoles substituídos e sua utilização | |
| DeLeve | Cancer chemotherapy | |
| MX2022000394A (es) | Combinaciones terapeuticas de paclitaxel oralmente administrado y un inhibidor de la bomba de p-glicoproteina (p-gp) para el tratamiento del cancer. | |
| BR102012028120B8 (pt) | Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento | |
| Theyab et al. | Angiotensin-converting enzyme inhibitor-induced angioedema | |
| Dourish et al. | Anti-obesity drugs: from animal models to clinical efficacy | |
| Fabiny | Ask the doctor. I have just stopped taking a statin drug because it was causing muscle pain. To control my cholesterol I'm now taking ground flaxseed and a daily red yeast rice pill. Are these supplements effective for lowering cholesterol? | |
| Celona et al. | 1030–Ocular pigmentation and cataract in therapy with phenothiazine | |
| Yu | Application of reiki on depression in nursing: a literature review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |